Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OMALIZUMAB vs OMNIPAQUE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OMALIZUMAB vs OMNIPAQUE: Safety Overview

Metric OMALIZUMAB OMNIPAQUE
Total FAERS Reports 63,846 253
Deaths Reported 1,713 10
Death Rate 2.7% 4.0%
Hospitalizations 11,178 60
Average Patient Age 51.0 yrs 57.1 yrs
% Female Patients 72.5% N/A
Manufacturer CELLTRION, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A